Ghrelin-receptor agonism
Acting on the ghrelin / GH-secretagogue receptor to release growth hormone.
Growth-hormone-releasing peptides (GHRPs) act on the ghrelin (GH-secretagogue) receptor — a pathway distinct from GHRH. Some also influence appetite signalling. They are frequently studied alongside GHRH analogs because the two pathways can act together.
Peptides acting through this pathway
FAQ
What does ghrelin-receptor agonism do?
Growth-hormone-releasing peptides (GHRPs) act on the ghrelin (GH-secretagogue) receptor — a pathway distinct from GHRH. Some also influence appetite signalling. They are frequently studied alongside GHRH analogs because the two pathways can act together.
Which peptides act through ghrelin-receptor agonism?
Ipamorelin, Hexarelin, Ghrp 2, Ghrp 6. They share this pathway but differ in evidence, approval, and safety.
Does this mechanism prove a peptide works?
No. Mechanistic plausibility is not proof of clinical benefit — a plausible pathway is a reason to study a compound, not evidence that it works in humans.
Mechanistic plausibility is not proof of clinical benefit. Research reference only — not medical advice.